BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35894473)

  • 1. OMICs Technologies for Natural Compounds-based Drug Development.
    Aborode AT; Awuah WA; Mikhailova T; Abdul-Rahman T; Pavlock S; Kundu M; Yarlagadda R; Pustake M; Correia IFDS; Mehmood Q; Shah P; Mehta A; Ahmad S; Asekun A; Nansubuga EP; Amaka SO; Shkodina AD; Alexiou A
    Curr Top Med Chem; 2022 Oct; 22(21):1751-1765. PubMed ID: 35894473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of omics- and multi-omics-based techniques for natural product target discovery.
    Zhang HW; Lv C; Zhang LJ; Guo X; Shen YW; Nagle DG; Zhou YD; Liu SH; Zhang WD; Luan X
    Biomed Pharmacother; 2021 Sep; 141():111833. PubMed ID: 34175822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
    Cisek K; Krochmal M; Klein J; Mischak H
    Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining for Microbial Gems: Integrating Proteomics in the Postgenomic Natural Product Discovery Pipeline.
    Du C; van Wezel GP
    Proteomics; 2018 Sep; 18(18):e1700332. PubMed ID: 29708658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease in the omics era.
    Sancesario GM; Bernardini S
    Clin Biochem; 2018 Sep; 59():9-16. PubMed ID: 29920246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Integrated Multi-omics Analysis for Drug-Target Identification.
    Du P; Fan R; Zhang N; Wu C; Zhang Y
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine Natural Products from Microalgae: An -Omics Overview.
    Lauritano C; Ferrante MI; Rogato A
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31067655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From genomics to metabolomics, moving toward an integrated strategy for the discovery of fungal secondary metabolites.
    Hautbergue T; Jamin EL; Debrauwer L; Puel O; Oswald IP
    Nat Prod Rep; 2018 Feb; 35(2):147-173. PubMed ID: 29384544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.
    Russell C; Rahman A; Mohammed AR
    Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From single- to multi-omics: future research trends in medicinal plants.
    Yang L; Yang Y; Huang L; Cui X; Liu Y
    Brief Bioinform; 2023 Jan; 24(1):. PubMed ID: 36416120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics Approaches to Pesticide Biodegradation.
    Rodríguez A; Castrejón-Godínez ML; Salazar-Bustamante E; Gama-Martínez Y; Sánchez-Salinas E; Mussali-Galante P; Tovar-Sánchez E; Ortiz-Hernández ML
    Curr Microbiol; 2020 Apr; 77(4):545-563. PubMed ID: 32078006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.
    Thomford NE; Senthebane DA; Rowe A; Munro D; Seele P; Maroyi A; Dzobo K
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29799486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Online tools for bioinformatics analyses in nutrition sciences.
    Malkaram SA; Hassan YI; Zempleni J
    Adv Nutr; 2012 Sep; 3(5):654-65. PubMed ID: 22983844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. User guides for biologists to learn computational methods.
    Na D
    J Microbiol; 2020 Mar; 58(3):173-175. PubMed ID: 32108313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second Era of OMICS in Caries Research: Moving Past the Phase of Disillusionment.
    Nascimento MM; Zaura E; Mira A; Takahashi N; Ten Cate JM
    J Dent Res; 2017 Jul; 96(7):733-740. PubMed ID: 28384412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics approaches for the assessment of biological responses to nanoparticles.
    Abdelkader Y; Perez-Davalos L; LeDuc R; Zahedi RP; Labouta HI
    Adv Drug Deliv Rev; 2023 Sep; 200():114992. PubMed ID: 37414362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of high-throughput omics technologies in medicinal plant research: The new era of natural drug discovery.
    Zhang W; Zeng Y; Jiao M; Ye C; Li Y; Liu C; Wang J
    Front Plant Sci; 2023; 14():1073848. PubMed ID: 36743502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The systems medicine of neonatal abstinence syndrome.
    Stone WL; Wood DL; Justice NA; Shah DS; Olsen ME; Bharti D
    Front Biosci (Landmark Ed); 2020 Jan; 25(4):736-759. PubMed ID: 31585915
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.